Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Lymphocyte Enhancement in Gastroenteric Oncology

NCT06343272
completednot_applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

NCT02442908
completednot_applicable

Improving Rehabilitation In Sarcopenia (IRIS)

NCT03120026
completednot_applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

NCT02515032

Clinical Trials (4)

Showing 4 of 4 trials
NCT06343272Not Applicable

Lymphocyte Enhancement in Gastroenteric Oncology

Recruiting
NCT02442908Not Applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

Completed
NCT03120026Not Applicable

Improving Rehabilitation In Sarcopenia (IRIS)

Completed
NCT02515032Not Applicable

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in NSCLC Cachexia

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4